Author： Montenez J.-P. Van Bambeke F. Piret J. Schanck A. Brasseur R. Tulkens P.M. Mingeot-Leclercq M.-P.
Publisher： Elsevier
ISSN： 0014-2999
Source： European Journal of Pharmacology, Vol.314, Iss.1, 1996-10, pp. : 215-227
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Van Bambeke F. Montenez J.-P. Piret J. Tulkens P.M. Courtoy P.J. Mingeot-Leclercq M.-P.
European Journal of Pharmacology, Vol. 314, Iss. 1, 1996-10 ,pp. :
Access to resources
Recommend
By Berquand A. Fa N. Dufrêne Y. F. Mingeot-Leclercq M.-P.
Pharmaceutical Research, Vol. 22, Iss. 3, 2005-03 ,pp. :
Strategy of Computer-Aided Drug Design
Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 1, 2003-03 ,pp. :
Computer-Aided Design of Antimicrobial Peptides
Current Pharmaceutical Analysis, Vol. 6, Iss. 2, 2010-05 ,pp. :
Proteomics in Computer-Aided Drug Design
Current Computer - Aided Drug Design, Vol. 1, Iss. 1, 2005-01 ,pp. :